Enovix (ENVX) CAO Kristina Truong Sells $6.8K of Stock

Kristina Truong sold 1,015 Enovix shares for $6,759.90 on June 13, 2026.

Reviewed by automated data checks against the source filing. How we make and check alerts

Kristina Truong, Chief Accounting Officer at Enovix Corporation ($ENVX), sold 1,015 shares at an average price of $6.66, worth about $6,759.90, on June 13, 2026. The trade was reported to the SEC in a Form 4 filing.

Since the trade, $ENVX is up 5.9% after 1 week, down 25.7% after 1 month and down 62.6% to date (from the $6.66 close on Jun 12, 2026).

Find the original: ENVX Form 4 filings on SEC EDGAR

ENVX Enovix Corporation
$2.49 -68.44% year to date
Daily close · Oct 16, 2026

Key Points

  • Enovix's Chief Accounting Officer Kristina Truong sold 1,015 shares on June 13, 2026, valued at $6,759.90.
  • Enovix trades on the NasdaqGS with a market cap of approximately $1.54 billion, and a 52-week range between $4.62 and $16.49.
  • Analysts maintain a buy consensus for Enovix with a mean price target of $13.10, highlighting potential growth.

Get $ENVX trade alerts by text

We text you when insiders, Congress or big funds trade $ENVX. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Enovix Corporation alert may contain errors. Disclosures

Kristina Truong, the Chief Accounting Officer of Enovix Corporation, sold 1,015 shares of the company on June 13, 2026. The transaction was valued at approximately $6,759.90, with shares sold at an average price of $6.66. This sale was not part of a pre-planned trading program.

Insider Buying and Selling at Enovix Corporation

Several other insiders have been active at Enovix recently. Joseph Ian Malchow, Pegah Ebrahimi, Gregory Reichow, Daniel McCranie, and Betsy Atkins each acquired 29,104 shares on June 11, 2026, without a specified purchase price, indicating significant insider interest in the company.

Other Institutional Activity in Enovix

Among institutional investors, BlackRock, Inc. increased its position by 1,280,739 shares, now holding 15,330,789 shares valued at about $79.4 million. Vanguard Capital Management LLC and Vanguard Portfolio Management LLC both initiated new positions, acquiring 8,379,238 and 8,051,198 shares, respectively. UBS Group AG slightly reduced its stake by 205,274 shares, holding 5,770,071 shares worth around $29.9 million. Geode Capital Management, LLC added 458,598 shares, bringing its total to 4,872,090 shares.

Enovix Corporation Stock Up 136.8%

Shares of NasdaqGS:ENVX were trading near $7.08. Enovix has a market capitalization of about $1.54 billion and shows a forward P/E ratio that is not meaningful due to its lack of profitability. The stock has a beta of 2.215, indicating higher volatility compared to the market. Its 52-week range spans from $4.62 to $16.49, with a 50-day moving average of $6.74 and a 200-day moving average of $7.84.

Recent Earnings

Enovix reported revenues of $34.32 million with a revenue growth rate of 49.1%. However, the company is not currently profitable, reflected in a net margin of 0% and a return on equity of -71.3%. Investors are looking forward to the next earnings announcement scheduled for July 29, 2026.

Analysts Set New Price Targets

Analysts have maintained a positive outlook on Enovix. On May 14, 2026, Oppenheimer, Craig-Hallum, and Benchmark reiterated their buy ratings, with price targets of $21, $8, and $15, respectively. TD Cowen maintained a hold rating with a $7 target. Enovix's consensus rating remains a buy, with an average target price of $13.10 based on 10 analyst opinions.

About Enovix Corporation

Enovix Corporation, headquartered in Fremont, California, designs and manufactures advanced lithium-ion battery cells. The company serves a variety of sectors, including wearables, smartphones, and electric vehicles. Founded in 2006, Enovix is led by CEO Dr. Raj Talluri and employs 664 people.

Bottom Line

Kristina Truong's recent sale of Enovix shares is noteworthy, but it comes amid a backdrop of significant insider buying and positive institutional interest. Analysts continue to see potential in Enovix, maintaining a buy consensus with price targets suggesting room for growth. It's important to remember that insider transactions and 13F filings provide historical data and might not reflect current positions.

Source: Kristina Truong's Form 4 filing on $ENVX (Jun 13, 2026). Find the original filing: ENVX Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts

Get $ENVX trade alerts by text